Credit Suisse Downgrades Gilead Sciences To Neutral


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Analysts at Credit Suisse downgraded

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Gilead Sciences Inc. (NASDAQ: GILD) from Outperform to Neutral.The price target for Gilead Sciences has been lowered from $130 to $115.Gilead Sciences shares have surged 26.86% over the past 52 weeks, while the S&P 500 index has gained 14.77% in the same period.Gilead Sciences' shares fell 1.15% to $98.75 in pre-market trading.
Posted In: DowngradesAnalyst RatingsCredit Suisse